Skip to content

Soft Part Management for Surgical Fractures of the Lower Limb

Interest of Preoperative Corticosteroid Therapy for Surgical Fractures of the Lower Limb

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03915223
Acronym
ICOMI
Enrollment
104
Registered
2019-04-16
Start date
2019-05-10
Completion date
2024-05-06
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edema, Fracture, Leg Injuries

Keywords

preoperative procedure, leg fractures, osteosynthesis, corticosteroids

Brief summary

The assessment consists in comparing corticoids injection versus placebo in surgery of lower limb fractures The aim of study is to assess (state cutaneous, efficacy, safety) corticoids injection on a prospective, randomized analysis

Detailed description

One of the major problems of below-knee fractures is edema (delaying surgery time and post-operative complications for healing). The effect corticosteroids (anti-edema and anti-inflammatory) is used in neurosurgery and maxillofacial surgery. So, it seemed judicious to evaluate the effectiveness of corticosteroids in bolus preoperatively in order to limit the importance of the edema before intervention to prevent adverse effect of the edema on the cicatrization. This study will aim to confirm this indication or not on the contrary to change current practices.

Interventions

PROCEDUREleg fracture

Surgical leg fracture with injection of solumedrol (steroidal anti-inflammatory drug) or physiological serum

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

double blinded

Intervention model description

Solumedrol (steroidal anti-inflammatory drug) injection

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient over the age of 18, hospitalized in the Orthopedics Department for a leg fracture (ankle, tibia: proximal, diaphysis, distal) requiring surgery within 72 hours of the trauma * Patient covered by the social security system * Patient giving informed consent

Exclusion criteria

* Open fracture with infectious risks cauchoix 2 and 3 * Multiple trauma, * Pathological fracture on primary or secondary lesions, * Pre-existing bone disease (excluding osteoporosis) of the operated limb, * Diabetes, * Pre-existing trophic disorders on one of the 2 lower limbs, * Long-term corticotherapy, * Pathology of the pituitary-adrenal axis, * Any other contraindication to glucocorticoids: any infectious condition, some developing viral diseases (including hepatitis, herpes, chicken pox, shingles), hypersensitivity to one of the constituents * Hypernatremia and hypochloremia * Pre-existing severe cardiac injury * Contraindication to TegadermTM * Patient placed under guardianship, tutorship or safeguard of justice, * Pregnant or lactating women,

Design outcomes

Primary

MeasureTime frameDescription
leg perimeter2 daysmeasure of leg perimeter at the fractured area compared to the contralateral side

Secondary

MeasureTime frameDescription
leg perimeter15 daysmeasure of leg perimeter at the fractured area compared to the contralateral side
pain legpreoperativeTHE VISUAL SIMILAR SCALE is auto-completed. For the intensity of pain, the scale varies between " no pain " (the score of 0) and " the pain so badly as he could be " or " the worst conceivable pain " (the score of 10)
State cutaneous7 daysindex form of follow-up the state cutaneous of the wound
Lower limb functional scale (EFMI)6 monthsThe Lower limb functional scale grading system uses 100 points to assess pain, function and mobility of the leg. The score varies between 0 and 100, more the value is better brought up is the score
Complications6 monthslist of the complications : Phlyctenes, scar disunity, cutaneous necrosis, infection, phlebitis, compartment syndrome, complex regional pain syndrome, delay of bone consolidation

Countries

France

Contacts

PRINCIPAL_INVESTIGATORStéphane Boisgard

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026